慢性多卢特格拉维尔给药对威斯塔尔老鼠微量氨基的作用
Natasha Henning1,2, Tracy A Kellermann1, Carine Smith3
1Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Drugs in R&D
|August 23, 2024
概括
在老鼠中,多卢特格拉维尔 (DTG) 治疗并没有显著改变总体的微量氨基特征. 然而,DTG确实降低了特定的阴和尿胺,这需要在艾滋病毒患者中进行进一步的临床研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
背景情况:
- 多卢特格拉维尔 (DTG) 是一线HIV治疗,具有潜在的代谢和分泌不良反应.
- 微氨基系统在慢性疾病中起作用,影响神经和炎症的结果.
- 微量氨基是生物原氨基,在健康和疾病中起作用,受内源性生产和饮食的影响.
研究的目的:
- 为了研究多卢特格拉维尔 (DTG) 对微量氨基的影响,在怀斯塔尔鼠模型中.
- 评估DTG给药后血液,尿液和组织中微量胺度的潜在变化.
主要方法:
- 维斯塔大鼠被分为男性/女性对照组和DTG治疗组12周.
- 收集了血液和组织样本 (尿液,血,大脑,胃肠道).
- 液体染色学-并联质谱学 (LC-MS/MS) 量化微量胺度.
主要成果:
- 在各种矩阵中,在雄性和雌性大鼠之间观察到聚胺水平的显著差异.
- DTG的使用导致阴 tyramine和尿液 synephrine 水平显著降低 (p < 0.05).
结论:
- 目前,DTG对大鼠的微氨基样本的影响并没有引起重大安全问题.
- 鉴于微氨酸在艾滋病毒等疾病中的作用,需要进一步的临床研究来评估DTG在这种特征上的重要性.
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...